Gemcitabine, cisplatin and methylprednisolone chemotherapy (GEM-P) is an effective regimen in patients with poor prognostic primary progressive or multiply relapsed Hodgkin's and non-Hodgkin's lymphoma-Reference-Cited by-同舟云学术

Gemcitabine, cisplatin and methylprednisolone chemotherapy (GEM-P) is an effective regimen in patients with poor prognostic primary progressive or multiply relapsed Hodgkin's and non-Hodgkin's lymphoma

Published:2003-03 Issue:6 Volume:120 Page:970-977
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Chau Ian,Harries Mark,Cunningham David,Hill Mark,Ross Paul J.,Archer Caroline D.,Norman Andrew R.,Wotherspoon Andrew,Koh Dow Mu,Gill Kairen,Uzzell Maggie,Prior Yvonne,Catovsky Daniel

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2003.04226.x/fullpdf

Reference50 articles.

1. Combined cisplatin and gemcitabine for non-small cell lung cancer: influence of scheduling on toxicity and drug delivery;Abratt;Seminars in Oncology,1998

2. Problems in Hodgkin's disease management;Aisenberg;Blood,1999

3. Phase I evaluation of prolonged-infusion gemcitabine with irinotecan for relapsed or refractory leukemia or lymphoma;Bass;Journal of Clinical Oncology,2002

4. Promising activity of gemcitabine in refractory high-grade non-Hodgkin's lymphoma;Bernell;British Journal of Haematology,1998

5. The International Prognostic Index correlates to survival in patients with aggressive lymphoma in relapse: analysis of the PARMA trial. Parma Group;Blay;Blood,1998

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Salvage Therapy Options for Initial Treatment of Relapsed/Refractory Classical Hodgkin’s Lymphoma: So Many Options, How to Choose?;Cancers;2022-07-20

2. Cancers of the Blood;Fundamentals of Cancer Detection, Treatment, and Prevention;2022-05-13

3. Clinical Outcomes of Advanced-Stage Cutaneous Lymphoma under Low-Dose Gemcitabine Treatment: Real-Life Data from the German Cutaneous Lymphoma Network;Dermatology;2021-09-02

4. Novel Therapy Approaches to Follicular Lymphoma;Drugs;2021-02-22

5. Optimizing outcomes in relapsed/refractory Hodgkin lymphoma: a review of current and forthcoming therapeutic strategies;Therapeutic Advances in Hematology;2020-01